<p>根据最近向美国证券交易委员会提交的 13F 文件，Nordea Investment Management AB 在 2023 年第二季度将其在 Organon &amp; Co.（纽约证券交易所代码：OGN - 免费报告）的股份增加了 1.1%。该基金在本季度购买了额外的 53,733 股后，持有该公司 4,904,076 股股票。在最近的报告期结束时，Nordea Investment Management AB 持有的 Organon &amp; Co.的股份约占 1.89%，价值 48,281,000 美元。</p>
<p>获取 <strong>Organon &amp; Co.</strong> 的提醒：</p>
<ul>
<li>道琼斯最热门的股票默克准备发布第四季度财报</li>
</ul>
<p>其他几家机构投资者最近也买卖了 OGN 的股票。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Organon &amp; Co.的持仓增加了 870.8%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在拥有 1,010,789 股该公司的股票，价值 15,051,000 美元，此前在上个季度购买了 906,675 股。马萨诸塞金融服务公司（Massachusetts Financial Services Co. MA）在第一季度将其在 Organon &amp; Co.的持仓增加了 8.3%。马萨诸塞金融服务公司（Massachusetts Financial Services Co. MA）现在拥有 10,715,445 股该公司的股票，价值 159,553,000 美元，此前在上个季度购买了 820,378 股。高盛集团（Goldman Sachs Group Inc.）在第一季度将其在 Organon &amp; Co.的持仓增加了 126.4%。高盛集团（Goldman Sachs Group Inc.）现在拥有 1,435,198 股该公司的股票，价值 21,370,000 美元，此前在此期间收购了 801,307 股。Gotham Asset Management LLC 在第一季度将其在 Organon &amp; Co.的持仓增加了 74.3%。Gotham Asset Management LLC 现在拥有 1,400,250 股该公司的股票，价值 20,850,000 美元，此前在此期间收购了 596,936 股。最后，Nuveen LLC 在第一季度购买了 Organon &amp; Co.的新头寸，价值约为 8,773,000 美元。77.43% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Organon &amp; Co. 价格表现</h2>
<p>OGN 在周五开盘价为 9.28 美元。该公司的债务与股本比率为 11.98，速动比率为 1.13，流动比率为 1.65。该股票的市值为 24.1 亿美元，市盈率为 3.45，市盈增长比率为 0.84，贝塔值为 0.63。该公司的 50 日简单移动平均线为 9.93 美元，200 日简单移动平均线为 10.02 美元。Organon &amp; Co.的 52 周低点为 8.01 美元，52 周高点为 19.05 美元。</p>
<ul>
<li>Lululemon Athletica 因进入标准普尔 500 指数而创下新高</li>
</ul>
<p>Organon &amp; Co.（纽约证券交易所代码：OGN - 获取免费报告）最近于 8 月 5 日星期二发布了季度财报。该公司报告本季度每股收益为 1.00 美元，超出市场共识预期的 0.94 美元，超出幅度为 0.06 美元。Organon &amp; Co.的净利润率为 11.15%，股本回报率为 163.88%。该公司本季度的收入为 15.9 亿美元，而分析师的预期为 15.5 亿美元。在去年同期，该公司每股收益为 1.12 美元。该公司的季度收入同比下降了 0.8%。Organon &amp; Co.已设定 2025 财年的每股收益指导。整体来看，分析师预测 Organon &amp; Co.在当前年度的每股收益为 3.68 美元。</p>
<h2>Organon &amp; Co. 股息公告</h2>
<p>该公司最近还披露了季度股息，该股息于 9 月 11 日星期四支付。8 月 15 日星期五的股东获得了 0.02 美元的股息。这代表着每年 0.08 美元的股息和 0.9% 的股息收益率。除息日期为 8 月 15 日星期五。Organon &amp; Co.的股息支付比率为 2.97%。</p>
<h2>华尔街分析师观点</h2>
<p>另外，Weiss Ratings 在 10 月 8 日星期三的研究报告中重申了对 Organon &amp; Co.股票的 “卖出（d+）” 评级。一位投资分析师对该股票给予了强烈买入评级，两位给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，Organon &amp; Co.目前的平均评级为 “适度买入”，共识目标价为 17.33 美元。</p>
<p><strong>查看我们关于 Organon &amp; Co.的最新研究报告</strong></p>
<h2>Organon &amp; Co. 公司简介</h2>
<p>（免费报告）</p>
<p>Organon &amp; Co.是一家基于科学的全球制药公司，通过一系列处方疗法在女性健康、生物仿制药和成熟品牌领域开发和提供创新的健康解决方案。该公司成立于 2020 年 3 月 11 日，总部位于新泽西州泽西市。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，而不是 Organon &amp; Co.</li>
<li>复利及其在投资中的重要性</li>
<li>强生的并购战略才是投资者真正关注的故事</li>
<li>10 只最佳航空公司股票</li>
<li>特斯拉：一些分析师预测将下跌 30%——是时候恐慌了吗？</li>
<li>10 美元以下的最佳股票</li>
<li>对冲基金对美元的态度转变——这三只股票的买入信号？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9HTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9HTg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Organon &amp; Co.吗？</h2>
<p>在考虑投资 Organon &amp; Co.之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场关注之前购买……而 Organon &amp; Co.并不在名单上。</p>
<p>虽然 Organon &amp; Co.目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Nordea Investment Management AB 在第二季度将其在 Organon & Co. (NYSE: OGN) 的持股比例增加了 1.1%，目前持有 4,904,076 股，价值 4828 万美元。其他机构投资者也显著增加了他们的持仓。Organon 报告第二季度每股收益为 1.00 美元，超出预期，收入为 15.9 亿美元。该公司的市值为 24.1 亿美元，股息收益率为 0.9%。分析师对该股票的评级不一，平均评级为 “适度买入”，目标价格为 17.33 美元</p>

<p>Nordea Investment Management AB boosted its position in shares of Organon &amp; Co. (NYSE:OGN - Free Report) by 1.1% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 4,904,076 shares of the company's stock after purchasing an additional 53,733 shares during the quarter. Nordea Investment Management AB owned about 1.89% of Organon &amp; Co. worth $48,281,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>根据最近向美国证券交易委员会提交的 13F 文件，Nordea Investment Management AB 在 2023 年第二季度将其在 Organon &amp; Co.（纽约证券交易所代码：OGN - 免费报告）的股份增加了 1.1%。该基金在本季度购买了额外的 53,733 股后，持有该公司 4,904,076 股股票。在最近的报告期结束时，Nordea Investment Management AB 持有的 Organon &amp; Co.的股份约占 1.89%，价值 48,281,000 美元。</p>
</div><p>Get <strong>Organon &amp; Co.</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Organon &amp; Co.</strong> 的提醒：</p>
</div><ul>
<li>Merck, the Dow's hottest stock, gets set to report Q4 financials</li>
</ul>
<div class="lb-trans"><ul>
<li>道琼斯最热门的股票默克准备发布第四季度财报</li>
</ul>
</div><p>Several other institutional investors also recently bought and sold shares of OGN. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Organon &amp; Co. by 870.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,010,789 shares of the company's stock valued at $15,051,000 after purchasing an additional 906,675 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in Organon &amp; Co. by 8.3% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 10,715,445 shares of the company's stock valued at $159,553,000 after purchasing an additional 820,378 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in Organon &amp; Co. by 126.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,435,198 shares of the company's stock valued at $21,370,000 after acquiring an additional 801,307 shares during the period. Gotham Asset Management LLC lifted its stake in Organon &amp; Co. by 74.3% during the 1st quarter. Gotham Asset Management LLC now owns 1,400,250 shares of the company's stock valued at $20,850,000 after acquiring an additional 596,936 shares during the period. Finally, Nuveen LLC bought a new position in Organon &amp; Co. during the 1st quarter valued at about $8,773,000. 77.43% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他几家机构投资者最近也买卖了 OGN 的股票。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Organon &amp; Co.的持仓增加了 870.8%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在拥有 1,010,789 股该公司的股票，价值 15,051,000 美元，此前在上个季度购买了 906,675 股。马萨诸塞金融服务公司（Massachusetts Financial Services Co. MA）在第一季度将其在 Organon &amp; Co.的持仓增加了 8.3%。马萨诸塞金融服务公司（Massachusetts Financial Services Co. MA）现在拥有 10,715,445 股该公司的股票，价值 159,553,000 美元，此前在上个季度购买了 820,378 股。高盛集团（Goldman Sachs Group Inc.）在第一季度将其在 Organon &amp; Co.的持仓增加了 126.4%。高盛集团（Goldman Sachs Group Inc.）现在拥有 1,435,198 股该公司的股票，价值 21,370,000 美元，此前在此期间收购了 801,307 股。Gotham Asset Management LLC 在第一季度将其在 Organon &amp; Co.的持仓增加了 74.3%。Gotham Asset Management LLC 现在拥有 1,400,250 股该公司的股票，价值 20,850,000 美元，此前在此期间收购了 596,936 股。最后，Nuveen LLC 在第一季度购买了 Organon &amp; Co.的新头寸，价值约为 8,773,000 美元。77.43% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Organon &amp; Co. Price Performance</h2>
<div class="lb-trans"><h2>Organon &amp; Co. 价格表现</h2>
</div><p>OGN opened at $9.28 on Friday. The company has a debt-to-equity ratio of 11.98, a quick ratio of 1.13 and a current ratio of 1.65. The stock has a market capitalization of $2.41 billion, a P/E ratio of 3.45, a P/E/G ratio of 0.84 and a beta of 0.63. The company's 50-day simple moving average is $9.93 and its two-hundred day simple moving average is $10.02. Organon &amp; Co. has a 52-week low of $8.01 and a 52-week high of $19.05.</p>
<div class="lb-trans"><p>OGN 在周五开盘价为 9.28 美元。该公司的债务与股本比率为 11.98，速动比率为 1.13，流动比率为 1.65。该股票的市值为 24.1 亿美元，市盈率为 3.45，市盈增长比率为 0.84，贝塔值为 0.63。该公司的 50 日简单移动平均线为 9.93 美元，200 日简单移动平均线为 10.02 美元。Organon &amp; Co.的 52 周低点为 8.01 美元，52 周高点为 19.05 美元。</p>
</div><ul>
<li>Lululemon Athletica Races to New High with S&amp;P 500 Entry</li>
</ul>
<div class="lb-trans"><ul>
<li>Lululemon Athletica 因进入标准普尔 500 指数而创下新高</li>
</ul>
</div><p>Organon &amp; Co. (NYSE:OGN - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.06. Organon &amp; Co. had a net margin of 11.15% and a return on equity of 163.88%. The firm had revenue of $1.59 billion for the quarter, compared to analysts' expectations of $1.55 billion. During the same quarter in the prior year, the business earned $1.12 EPS. The business's quarterly revenue was down .8% on a year-over-year basis. Organon &amp; Co. has set its FY 2025 guidance at EPS. As a group, analysts predict that Organon &amp; Co. will post 3.68 EPS for the current year.</p>
<div class="lb-trans"><p>Organon &amp; Co.（纽约证券交易所代码：OGN - 获取免费报告）最近于 8 月 5 日星期二发布了季度财报。该公司报告本季度每股收益为 1.00 美元，超出市场共识预期的 0.94 美元，超出幅度为 0.06 美元。Organon &amp; Co.的净利润率为 11.15%，股本回报率为 163.88%。该公司本季度的收入为 15.9 亿美元，而分析师的预期为 15.5 亿美元。在去年同期，该公司每股收益为 1.12 美元。该公司的季度收入同比下降了 0.8%。Organon &amp; Co.已设定 2025 财年的每股收益指导。整体来看，分析师预测 Organon &amp; Co.在当前年度的每股收益为 3.68 美元。</p>
</div><h2>Organon &amp; Co. Dividend Announcement</h2>
<div class="lb-trans"><h2>Organon &amp; Co. 股息公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 11th. Stockholders of record on Friday, August 15th were paid a $0.02 dividend. This represents a $0.08 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Friday, August 15th. Organon &amp; Co.'s dividend payout ratio is 2.97%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，该股息于 9 月 11 日星期四支付。8 月 15 日星期五的股东获得了 0.02 美元的股息。这代表着每年 0.08 美元的股息和 0.9% 的股息收益率。除息日期为 8 月 15 日星期五。Organon &amp; Co.的股息支付比率为 2.97%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Separately, Weiss Ratings restated a &#34;sell (d+)&#34; rating on shares of Organon &amp; Co. in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Organon &amp; Co. presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $17.33.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 10 月 8 日星期三的研究报告中重申了对 Organon &amp; Co.股票的 “卖出（d+）” 评级。一位投资分析师对该股票给予了强烈买入评级，两位给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，Organon &amp; Co.目前的平均评级为 “适度买入”，共识目标价为 17.33 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on Organon &amp; Co.</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Organon &amp; Co.的最新研究报告</strong></p>
</div><h2>Organon &amp; Co. Company Profile</h2>
<div class="lb-trans"><h2>Organon &amp; Co. 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Organon &amp; Co is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.</p>
<div class="lb-trans"><p>Organon &amp; Co.是一家基于科学的全球制药公司，通过一系列处方疗法在女性健康、生物仿制药和成熟品牌领域开发和提供创新的健康解决方案。该公司成立于 2020 年 3 月 11 日，总部位于新泽西州泽西市。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Organon &amp; Co.</li>
<li>Compound Interest and Why It Matters When Investing</li>
<li>Johnson &amp; Johnson's M&amp;A Strategy Is the Real Story for Investors</li>
<li>10 Best Airline Stocks to Buy</li>
<li>Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?</li>
<li>Best Stocks Under $10.00</li>
<li>Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，而不是 Organon &amp; Co.</li>
<li>复利及其在投资中的重要性</li>
<li>强生的并购战略才是投资者真正关注的故事</li>
<li>10 只最佳航空公司股票</li>
<li>特斯拉：一些分析师预测将下跌 30%——是时候恐慌了吗？</li>
<li>10 美元以下的最佳股票</li>
<li>对冲基金对美元的态度转变——这三只股票的买入信号？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9HTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OGN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Organon &amp; Co. Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Organon &amp; Co.吗？</h2>
</div><p>Before you consider Organon &amp; Co., you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 Organon &amp; Co.之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organon &amp; Co. wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场关注之前购买……而 Organon &amp; Co.并不在名单上。</p>
</div><p>While Organon &amp; Co. currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Organon &amp; Co.目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Nordea Investment Management AB 增加了在 Organon & Co. $OGN 的持股